Research progress of the molecular pathogenesis in myelodysplastic syndromes
10.3760/cma.j.issn.1009-9921.2015.08.021
- VernacularTitle:骨髓增生异常综合征发病分子机制研究进展
- Author:
Miao HE
- Publication Type:Journal Article
- Keywords:
Myelodysplastic syndromes;
Gene mutation;
Molecular pathogenesis;
Gene expression
- From:
Journal of Leukemia & Lymphoma
2015;24(8):510-512
- CountryChina
- Language:Chinese
-
Abstract:
The pathogenesis-related genes of myelodysplastic syndrome (MDS) has became a hot spot in the whole world.The common genetic mutations in MDS include epigenetic regulator mutations (TET2,ASXL1,DNMT3A),RNA splicing mutations (SF3B1,SRSF2,U2AF1,ZRSR2),signal transduction regulators (NRAS,JAK2),transcription factors mutations (RUNX1,TP53) and so on.Each mutation plays an important role in the molecular mechanisms of the pathogenesis of MDS and is closely related with clinical phenotype,efficacy and prognosis.Further study of the molecular pathogenesis of MDS-related genes can promote exploring the mechanisms and new therapeutic strategies for MDS.
